- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.10. | Stats without stories: why journalists aren't covering your data | ||
| 02.10. | Sanofi/Regeneron's Dupixent approved by FDA to treat uncontrolled COPD | ||
| 02.10. | Roche's Genentech acquires Regor Pharmaceuticals' CDK inhibitors for $850m upfront | ||
| 02.10. | J&J and Legend share long-term results for Carvykti in phase 3 multiple myeloma study | ||
| 02.10. | Bristol Myers Squibb announces positive data for Sotyktu in moderate-to-severe psoriasis | ||
| 02.10. | Strategy execution - ensuring it all fits together | ||
| 01.10. | Roche's injectable C5 inhibitor PiaSky recommended by NICE for rare blood disorder PNH | ||
| 01.10. | Johnson & Johnson's Yuvanci granted EC approval to treat pulmonary arterial hypertension | ||
| 01.10. | FDA approves IntraBio's Aqneursa to treat Niemann-Pick disease type C patients | ||
| 01.10. | 'Causes That Count, Health' report - key issues affecting global health | ||
| 30.09. | MHRA approves Pharming's Joenja as first drug for rare immune disease APDS | ||
| 30.09. | Ipsen's Kayfanda granted EC approval to treat cholestatic pruritus in Alagille syndrome | ||
| 30.09. | British Skin Foundation receives £10,000 donation from Circle Health Group | ||
| 30.09. | A social imperative: pharma's essential role in online medical accuracy | ||
| 27.09. | AstraZeneca's Tagrisso approved by FDA to treat EGFR-mutated lung cancer | ||
| 27.09. | FDA grants rare paediatric disease designation to Enterprise's cystic fibrosis candidate | ||
| 27.09. | UCB shares positive two-year results for Bimzelx in hidradenitis suppurativa | ||
| 27.09. | Quality in Care (QiC) Dermatology 2025 | ||
| 26.09. | Sanofi's Sarclisa granted FDA approval to treat newly diagnosed multiple myeloma | ||
| 26.09. | LEO Pharma's Anzupgo cream approved by EC to treat chronic hand eczema | ||
| 26.09. | Eli Lilly/Almirall share positive long-term results for Ebglyss in atopic dermatitis | ||
| 26.09. | Drug safety risk analysis - solving the puzzle of unstructured data | ||
| 25.09. | Astellas' Vyloy combination approved by EC as first-line gastric cancer treatment | ||
| 25.09. | Pfizer/BioNTech's KP.2-adapted COVID-19 vaccine receives CHMP recommendation | ||
| 25.09. | FDA approves Zevra's Miplyffa as first drug for Niemann-Pick disease type C |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
